Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression

被引:67
作者
Li, Juanni [1 ,2 ]
Hu, Kuan [3 ]
Gong, Guanghui [1 ,2 ]
Zhu, Ding [1 ,2 ]
Wang, Yixuan [1 ,2 ]
Liu, Hailing [1 ,2 ]
Wu, Xiaoying [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Sch Basic Med Sci, Dept Pathol, Changsha, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Hepatobiliary Surg, Changsha, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
MESENCHYMAL TRANSITION; METASTASIS; EXPRESSION; MICRORNAS; INHIBITION; APOPTOSIS; EMT;
D O I
10.1038/srep41330
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MicroRNAs (miRNAs) function as critical regulators of gene expression and their deregulation is associated with the development and progression of various cancers. This study aimed to investigate the biological role and mechanism of miR-205 in ovarian cancer (OC). MiR-205 was upregulated in OC tissues and cells in comparison to the controls. Meanwhile, overexpression of miR-205 was significantly associated with poor overall survival of OC patients. Functional study indicated that ectopic expression of miR-205 significantly promoted cell proliferation, migration, invasion and chemoresistance of OC cells. SMAD4 and PTEN were identified as direct targets of miR-205 using luciferase reporter assays, real-time PCR (qRT-PCR), and western blot. Most interestingly, in vivo studies indicated that miR-205 markedly promoted the growth and metastasis of tumors and the expression of miR-205 was also found to be inversely correlated with that of SMAD4 and PTEN in nude mice. Overall, we suggest that miR-205 functions as an oncogenic miRNA by directly binding to SMAD4 and PTEN, providing a novel target for the molecular treatment of ovarian cancer.
引用
收藏
页数:9
相关论文
共 41 条
[1]   Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample [J].
Brain, Kate E. ;
Smits, Stephanie ;
Simon, Alice E. ;
Forbes, Lindsay J. ;
Roberts, Chris ;
Robbe, Iain J. ;
Steward, John ;
White, Ceri ;
Neal, Richard D. ;
Hanson, Jane .
BMC CANCER, 2014, 14
[2]   Low-Level Expression of MicroRNAs let-7d and miR-205 Are Prognostic Markers of Head and Neck Squamous Cell Carcinoma [J].
Childs, Geoffrey ;
Fazzari, Melissa ;
Kung, Gloria ;
Kawachi, Nicole ;
Brandwein-Gensler, Margaret ;
McLemore, Michael ;
Chen, Quan ;
Burk, Robert D. ;
Smith, Richard V. ;
Prystowsky, Michael B. ;
Belbin, Thomas J. ;
Schlecht, Nicolas F. .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (03) :736-745
[3]   Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives [J].
Diaz-Lopez, Antonio ;
Moreno-Bueno, Gema ;
Cano, Amparo .
CANCER MANAGEMENT AND RESEARCH, 2014, 6 :205-216
[4]   miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes [J].
Dweep, Harsh ;
Sticht, Carsten ;
Pandey, Priyanka ;
Gretz, Norbert .
JOURNAL OF BIOMEDICAL INFORMATICS, 2011, 44 (05) :839-847
[5]   Oncomirs - microRNAs with a role in cancer [J].
Esquela-Kerscher, A ;
Slack, FJ .
NATURE REVIEWS CANCER, 2006, 6 (04) :259-269
[6]   MiR-378 Inhibits Progression of Human Gastric Cancer MGC-803 Cells by Targeting MAPK1 In Vitro [J].
Fei, Bojian ;
Wu, Haorong .
ONCOLOGY RESEARCH, 2012, 20 (12) :557-564
[7]   microRNAs: Master Regulators as Potential Therapeutics in Cancer [J].
Garofalo, Michela ;
Croce, Carlo M. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011, 2011, 51 :25-43
[8]   Targeting microRNAs in cancer: rationale, strategies and challenges [J].
Garzon, Ramiro ;
Marcucci, Guido ;
Croce, Carlo M. .
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (10) :775-789
[9]   Ovarian carcinoma pathology and genetics: recent advances [J].
Gilks, C. Blake ;
Prat, Jaime .
HUMAN PATHOLOGY, 2009, 40 (09) :1213-1223
[10]   The role of miR-100 in regulating apoptosis of breast cancer cells [J].
Gong, Yi ;
He, Tianliang ;
Yang, Lu ;
Yang, Geng ;
Chen, Yulei ;
Zhang, Xiaobo .
SCIENTIFIC REPORTS, 2015, 5